MoneyWorks4Me

Aarti Pharmalabs - Quaterly Results

12 May 2023 Evaluate
The company's total revenue for the quarter ended March 2023 saw a slight change in the total revenue, having registered a total revenue of Rs. 3742.70 millions.Net profit declined -10.87% to Rs. 400.00 millions from Rs. 448.80 millions.OP of the company witnessed a marginal growth to 768.00 millions from 707.20 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 3742.70 3647.00 2.62 15112.50 9410.20 60.60 15112.50 9410.20 60.60
Other Income 0.00 25.10 -100.00 12.80 25.10 -49.00 12.80 25.10 -49.00
PBIDT 768.00 707.20 8.60 3096.20 1822.90 69.85 3096.20 1822.90 69.85
Interest 58.00 44.00 31.82 204.90 113.40 80.69 204.90 113.40 80.69
PBDT 710.00 663.20 7.06 2891.30 1709.50 69.13 2891.30 1709.50 69.13
Depreciation 142.50 124.40 14.55 557.70 372.30 49.80 557.70 372.30 49.80
PBT 567.50 538.80 5.33 2333.60 1337.20 74.51 2333.60 1337.20 74.51
TAX 167.50 90.00 86.11 616.30 270.00 128.26 616.30 270.00 128.26
Deferred Tax 27.50 15.00 83.33 95.00 45.00 111.11 95.00 45.00 111.11
PAT 400.00 448.80 -10.87 1717.30 1067.20 60.92 1717.30 1067.20 60.92
Equity 453.10 455.60 -0.55 453.10 455.60 -0.55 453.10 455.60 -0.55
PBIDTM(%) 20.52 19.39 5.82 20.49 19.37 5.76 20.49 19.37 5.76
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..